US 11179394
Method for treating cancer using a combination of Chk1 and ATR inhibitors
granted A61KA61K31/4535A61K31/4709
Quick answer
US patent 11179394 (Method for treating cancer using a combination of Chk1 and ATR inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4535, A61K31/4709, A61K31/4965, A61K31/497